Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a centralized Locations section listing all participating sites by state (Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington). The previous per-state location headings were removed and the HHS Vulnerability Disclosure section was deleted.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 appears as a minor site version note in the page footer and does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the government funding status notice that previously appeared on the page. This maintenance change does not alter the study information, such as eligibility criteria, endpoints, or enrollment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedOnly minor layout adjustments are visible; core study content and key sections such as the overview and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating-status notice; removed the term 'IgA glomerulonephritis' from the content.SummaryDifference3%

- Check102 days agoChange DetectedThe page now shows Revision: v3.1.0, replacing the previous Revision: v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.